BOPW
INSY

Brandywine Oak Private Wealth’s Insys Therapeutics, Inc. INSY Stock Holding History

Brandywine Oak Private Wealth’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-246
Closed – – 722
2018
Q4 		$0 Buy
+246
New +$1.71K ﹤0.01% 734

Other funds holding INSY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Brandywine Oak Private Wealth's INSY Position: Q1 2019 in Review

Brandywine Oak Private Wealth sold out of Insys Therapeutics, Inc. (INSY) in Q1 2019, closing a stake of 246 shares.

Brandywine Oak Private Wealth first reported a position in INSY in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 98 funds tracked by Wall St. Rank hold INSY as of Q1 2019.

  • Brandywine Oak Private Wealth reported no remaining Insys Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
  • Brandywine Oak Private Wealth sold 246 Insys Therapeutics, Inc. shares in Q1 2019.
  • Brandywine Oak Private Wealth first reported a position in Insys Therapeutics, Inc. in Q4 2018 and held it in 1 quarter.
  • Brandywine Oak Private Wealth's Insys Therapeutics, Inc. position peaked at $0 in Q4 2018.
  • 98 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2019.

Based on Brandywine Oak Private Wealth's 13F filing for Q1 2019, filed 9 May 2019.